Transcriptomics Evidence for Common Pathways in Human Major Depressive Disorder and Glioblastoma
- PMID: 29329273
- PMCID: PMC5796182
- DOI: 10.3390/ijms19010234
Transcriptomics Evidence for Common Pathways in Human Major Depressive Disorder and Glioblastoma
Abstract
Depression as a common complication of brain tumors. Is there a possible common pathogenesis for depression and glioma? The most serious major depressive disorder (MDD) and glioblastoma (GBM) in both diseases are studied, to explore the common pathogenesis between the two diseases. In this article, we first rely on transcriptome data to obtain reliable and useful differentially expressed genes (DEGs) by differential expression analysis. Then, we used the transcriptomics of DEGs to find out and analyze the common pathway of MDD and GBM from three directions. Finally, we determine the important biological pathways that are common to MDD and GBM by statistical knowledge. Our findings provide the first direct transcriptomic evidence that common pathway in two diseases for the common pathogenesis of the human MDD and GBM. Our results provide a new reference methods and values for the study of the pathogenesis of depression and glioblastoma.
Keywords: common pathway; differentially expressed genes; glioblastoma; major depressive disorder; transcriptomics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Seddighi A., Seddighi A.S., Nikouei A., Ashrafi F., Nohesara S. Psychological aspects in brain tumor patients: A prospective study. Hell. J. Nucl. Med. 2015;18(Suppl. 1):63–67. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
